Hi,
moomoo ID:NaN
Log Out
English
Back
Log in to access Online Inquiry
Multi-dimentional Analyses
Company Valuation Capital Tracking Short Selling Data
Moomoo > Quotes > CYBN Cybin > Detailed Quotes

CYBN Cybin

Watchlist
0.440
-0.020-4.35%
Close  02/03 16:00 ET
0.450
+0.010+2.20%
Post Mkt Price 02/03 19:56 ET
High
0.469
Open
0.455
Turnover
717.83K
Low
0.400
Pre Close
0.460
Volume
1.64M
Market Cap
77.69M
P/E(TTM)
Loss
52wk High
1.160
Shares
176.56M
P/E(Static)
Loss
52wk Low
0.265
Float Cap
57.04M
Bid/Ask %
0.00%
Historical High
3.380
Shs Float
129.64M
Volume Ratio
0.78
Historical Low
0.265
Dividend TTM
--
Div Yield TTM
--
P/B
1.62
Dividend LFY
--
Div Yield LFY
--
Turnover Ratio
1.26%
Amplitude
15.07%
Avg Price
0.439
Lot Size
1
Float Cap
57.04M
Bid/Ask %
0.00%
Historical High
3.380
Shs Float
129.64M
Volume Ratio
0.78
Historical Low
0.265
Dividend TTM
--
P/B
1.62
Dividend LFY
--
Turnover Ratio
1.26%
Amplitude
15.07%
Avg Price
0.439
Lot Size
1
Price Forecast

News

Comment

Company Overview More
Cybin, Inc. is an ethical biopharmaceutical company engaged in the development of therapeutics for patients to address a multitude of mental health issues. It is focused on progressing psychedelics to therapeutics by engineering proprietary drug discovery platforms, innovative drug delivery systems, novel formulation approaches, and treatment regimens for mental health disorders. The company was founded by Paul Glavine, Eric So, and John Kanakis on October 13, 2016 and is headquartered in Toronto, Canada.
CEO: Mr. Douglas Drysdale
Market: AMEX
Listing Date: 08/05/2021
Paper Trade More
Direction
Buy
Sell
Types
LMT Order
Price
QTY
Amount
--
Hot List
TradeSearchNews
SymbolLatest price%Chg

Loading...

Watchlist